Where does Theranos IP Company, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Theranos IP Company, LLC ranks #5,251 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Theranos IP Company, LLC hold?

Theranos IP Company, LLC holds 66 US utility patents granted between 2018 and 2020, spanning 32 technology areas.

What is Theranos IP Company, LLC's Innovation Score?

Theranos IP Company, LLC has an Innovation Score of 44.9 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Theranos IP Company, LLC focus on?

Theranos IP Company, LLC's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 44 patents, ranking #336 of 7,863 assignees active in that subclass. Grants appear in 32 CPC subclasses total.

Is Theranos IP Company, LLC's patent grant rate increasing or decreasing?

Theranos IP Company, LLC's recent grant velocity is -68% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Theranos IP Company, LLC's patents?

Theranos IP Company, LLC's patents average 17.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Theranos IP Company, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Theranos IP Company, LLC

USPTO PatentsView assignee record - 66 granted patents across 32 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Theranos ranks #5,251 of 49,997 tracked US assignees by granted-patent volume, with 66 patents across 32 technology areas.

#5,251
of 49,997 US assignees by volume: Top 24%
by Innovation Score (44.9/100): 17.4
avg claims per patent: -68%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5251 · US Corporation #5,251 · 66 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 66 grants
UPPER-Q #5,251/49,997
PHOTO-FINISH Takeda Vaccines
CPC-FOCUS G01N · 32 areas
INNOV-PAR 44.9/100
CLAIMS-RICH 17.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -68% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Takeda Vaccines, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Theranos’s 44.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.5 pts (32%) Velocity 0.0 pts (0%) Breadth 20.0 pts (45%) Claim depth 10.4 pts (23%)

Qualcomm Incorporated · highest

85
Fourstar Group · near

45
Rearden · near

45
Theranos IP · this assignee

45
Voss Automotive · near

45
Central Japan… · near

45
3D Lighting… · lowest

7

What this shows Theranos's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Theranos?

Each dot is one of Theranos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Theranos’s own 17.4 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Theranos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Theranos's grants concentrate

Theranos IP Company, LLC is a focused PatentsView assignee: 32 CPC subclasses with 66.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2019 (27 grants) versus a trough of 16 in 2020. By volume, Theranos sits between Tekelec, Inc. and Xiamen Hithium Energy Storage Technology Co., Ltd..

Tekelec

66
TPK Advanced Solu…

66
Trek Bicycle

66
Takeda Vaccines

66
Toast

66
University of Pue…

66
Urschel Laborator…

66
Xiamen Hithium En…

66
Theranos IP ◀

66

What this shows Theranos holds 66 patents at rank #5,253, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Theranos

By rank, the assignees closest to #5,253 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Theranos's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Theranos, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Theranos ranks #336 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Fourstar Group Inc. 45 Rearden, LLC 45 Voss Automotive GmbH 45 Central Japan Railway Comany 45

Similar claim depth

Nearest assignees by average claims per patent (17.4 here).

Chugai Seiyaku Kabushiki Kaisha 17.4 avg Soitec 17.4 avg Visa International Service Association 17.4 avg Largan Digital Co., Ltd. 17.4 avg

Theranos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Theranos IP Company, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	23	34.8%
2019	27	40.9%
2020	16	24.2%

Which technologies does Theranos IP Company, LLC patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 44

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 32

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 20

Y10T - Technical Subjects Covered BY Former US Classification 15

A61B - DIAGNOSIS; SURGERY; Identification 12

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 8

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 5

G02B - Optical Elements, Systems OR Apparatus 4

Y02A - Technologies FOR Adaptation TO Climate Change 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

G06F - Electric Digital Data Processing 2

Top 15 of 32 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Theranos IP Company, LLC's patent record in context - here's where to go next.

Theranos IP Company, LLC's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 66.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #5,251 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Theranos IP Company, LLC against Tekelec, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.